Avantor Investor Day Presentation Deck

High purity silicones innovation drives outsized growth in proprietary materials BIOMATERIALS INNOVATION PIPELINE¹ 500+ innovation projects in progress Recurring revenue for the lifetime of the product (often >15 years) Navantor™ 1. All numbers as of Q2 2021 In situ therapies 200% Drug delivery platforms Ophthalmic applications 54

View entire presentation